We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDDT icon
126
Reddit
RDDT
$29B
$3.78M 0.06%
36,000
+17,000
+89% +$2.81M
ULTA icon
127
Ulta Beauty
ULTA
$23.2B
$3.75M 0.06%
10,236
-13,609
-57% -$5.19M
CBUS icon
128
Cibus
CBUS
$143M
$3.64M 0.05%
+1,948,000
New +$4.56M
RXST icon
129
RxSight
RXST
$253M
$3.59M 0.05%
+142,036
New +$4.22M
ANRO icon
130
Alto Neuroscience
ANRO
$1.11B
$3.46M 0.05%
1,600,000
+950,000
+146% +$3.4M
LEVI icon
131
Levi Strauss
LEVI
$9.35B
$3.43M 0.05%
220,000
-330,000
-60% -$5.74M
SCLX icon
132
Scilex Holding
SCLX
$48.8M
$3.43M 0.05%
394,057
-116,725
-23% -$1.47M
SYRE icon
133
Spyre Therapeutics
SYRE
$9.12B
$3.23M 0.05%
200,000
– –
AS icon
134
Amer Sports
AS
$21B
$2.91M 0.04%
+108,994
New +$3.22M
SPOT icon
135
Spotify
SPOT
$97.7B
$2.78M 0.04%
5,059
+276
+6% +$154K
RMTI icon
136
Rockwell Medical
RMTI
$28.3M
$2.67M 0.04%
236,614
-67,754
-22% -$1.23M
CPRI icon
137
Capri Holdings
CPRI
$1.7B
$2.66M 0.04%
135,000
-300,000
-69% -$6.64M
KYNB
138
Kyntra Bio
KYNB
$28.3M
$2.63M 0.04%
340,000
+68,000
+25% +$815K
NTLA icon
139
Intellia Therapeutics
NTLA
$1.57B
$2.59M 0.04%
+364,000
New +$3.68M
NB
140
NioCorp Developments
NB
$737M
$2.57M 0.04%
+1,306,273
New +$2.62M
TOON icon
141
Kartoon Studios
TOON
$35.1M
$2.54M 0.04%
4,095,934
-466,066
-10% -$267K
SPCB icon
142
SuperCom
SPCB
$65.8M
$2.42M 0.04%
+363,470
New +$3.44M
VSXY
143
Victoria's Secret
VSXY
$7.43B
$2.23M 0.03%
+120,000
New +$3.53M
CRIS icon
144
Curis
CRIS
$8.59M
$2.17M 0.03%
51,668
+47,868
+1,260% +$2.96M
MURA
145
DELISTED
Mural Oncology
MURA
$2.17M 0.03%
1,722,000
+22,000
+1% +$80.2K
MKZR
146
MacKenzie Realty Capital
MKZR
$3.38M
$2.17M 0.03%
+144,574
New +$3.05M
SDST
147
Stardust Power Inc
SDST
$6.68M
$2.13M 0.03%
+452,600
New +$5.57M
TGT icon
148
Target
TGT
$66.8B
$2.06M 0.03%
19,733
-35,790
-64% -$4.47M
ZURA icon
149
Zura Bio
ZURA
$542M
$1.98M 0.03%
1,536,000
+36,000
+2% +$56.8K
CLDI icon
150
Calidi Biotherapeutics
CLDI
$2.16M
$1.88M 0.03%
+17,302
New +$3.16M
4 5
6
7 8

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.